Kinase
Kinase: In biochemistry, a kinase is an enzyme that catalyzes the transfer of phosphate groups from high-energy, phosphate-donating molecules to specific substrates. This process is known as phosphorylation, where the substrate gains a phosphate group and the high-energy ATP molecule donates a phosphate group.
-
APR 09, 2019 09:00 AM PDTC.E. CREDITS
APR 09, 2019 09:00 AM PDTDATE: April 9, 2019TIME: 9:00 AM PDTWe will provide a general introduction to the Single-Cell Western Technology (SCW) and then present data from 2 ongoing projects from the Col...Speaker: Noemi Kedei, MD , Kelly Gardner, Ph.D.Sponsored By: ProteinSimpleDEC 06, 2018 03:00 PM CETC.E. CREDITS
DEC 06, 2018 03:00 PM CETDATE: December 6, 2018TIME:6:00am PST, 9:00am EST, 3:00pm CET Alterations in the bone and mineral...Speaker: Jean-Claude Souberbielle (JCS)Sponsored By: DiaSorinOCT 30, 2018 10:00 AM PDTC.E. CREDITS
OCT 30, 2018 10:00 AM PDTDATE: October 30, 2018TIME: 10:00am PT, 1:00pm ET Identification and quantification of post-translational modifications (PTM) presents a unique challenge to proteomic studies...Speaker: Birgit Schilling, PhD , Matthew Stokes, PhDSponsored By: Cell Signaling TechnologyOCT 11, 2018 01:30 PM PDTC.E. CREDITS
OCT 11, 2018 01:30 PM PDTAs the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...Speaker: Benjamin Anderson, MDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 12:00 PM PDTC.E. CREDITS
OCT 11, 2018 12:00 PM PDTLung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...Speaker: Nicholas McGranahan, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 10:30 AM PDTC.E. CREDITS
OCT 11, 2018 10:30 AM PDTTwo projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...Speaker: Kevin Williams, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 09:00 AM PDTC.E. CREDITS
OCT 11, 2018 09:00 AM PDTThe oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...Speaker: Jason De Melo, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 07:30 AM PDTC.E. CREDITS
OCT 11, 2018 07:30 AM PDTIn the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...Speaker: Krastan Blagoev, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 06:00 AM PDTC.E. CREDITS
OCT 11, 2018 06:00 AM PDTPacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...Speaker: Jonas Korlach, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 12:00 PM PDTC.E. CREDITS
OCT 10, 2018 12:00 PM PDTRNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...Speaker: Jonathan Shaffer, MBA, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: QIAGENOCT 10, 2018 12:00 PM PDTC.E. CREDITS
OCT 10, 2018 12:00 PM PDTTo date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...Speaker: Jerome Galon, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 09:00 AM PDTC.E. CREDITS
OCT 10, 2018 09:00 AM PDTIn prior work, we have pursued how tumor reactive monoclonal antibody (mAb), together with activators of innate immune cells, like NK cells, can augment antibody dependent cell-mediated cytot...Speaker: Paul Sondel, MD, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 09:00 AM PDTC.E. CREDITS
OCT 10, 2018 09:00 AM PDTHigh-throughput screening is widely useful in identifying genes and pathways that drive changes in cell behavior such as cell cycle regulation, metastasis, and drug resistance. Millipor...Speaker: Andrew Ravanelli, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: MilliporeSigmaOCT 10, 2018 07:30 AM PDTC.E. CREDITS
OCT 10, 2018 07:30 AM PDTMolecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...Speaker: Karin Rodland, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 06:00 AM PDTC.E. CREDITS
OCT 10, 2018 06:00 AM PDTUnderstanding the immune repertoire is an important aspect of immuno-oncology research, which can be used to gather insights into the function and overall status of the immune system. We have...Speaker: Samuel Rulli, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: QIAGENMAR 15, 2018 09:00 AM PDTC.E. CREDITS
MAR 15, 2018 09:00 AM PDTThe inability of neurons to regenerate damaged axons within the CNS has dire consequences for victims of traumatic or ischemic brain injury and multiple neurodegenerative diseases. Like other...Speaker: Larry Benowitz, PhDPresented At:Neuroscience 2018FEB 21, 2018 12:00 PM PSTC.E. CREDITS
FEB 21, 2018 12:00 PM PSTRett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the Methyl CpG Binding Protein 2 (MECP2) gene. In mouse models of RTT, deficits in long-term potentiation (LTP) at...Speaker: Colleen Niswender, PhDPresented At:Drug Discovery 2018FEB 21, 2018 09:00 AM PSTC.E. CREDITS
FEB 21, 2018 09:00 AM PSTThere are many tumor biomarkers but, they mostly reflect tumor mass or past growth, when what is more important is to obtain an indication of future growth and therapy response.Proliferat...Speaker: Martin ShawPresented At:Drug Discovery 2018JAN 25, 2018 08:00 AM PSTC.E. CREDITS
JAN 25, 2018 08:00 AM PSTDATE: January 25, 2018TIME: 8:00AM PST, 10:00AM CSTProstate cancer (PCa) is the most common noncutaneous malignancy in men in the US. A significant fraction of advanced PCa treate...Speaker: Xin Lu, PhDSponsored By: Bio-TechneNOV 14, 2017 09:00 AM PSTC.E. CREDITS
NOV 14, 2017 09:00 AM PSTDATE: November 14, 2017TIME: 09:00am PST, 12:00pm ESTThe CRISPR-Cas9 system has been adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and av...Speaker: Žaklina Strezoska , Benedict CrossSponsored By: Dharmacon, a Horizon Discovery Group Company
For more than four decades, restrictions on research with psychoactive drugs have slowed progress in understanding how such substances impact brain metabolism. Besides the historical restrict...Speaker: Stevens RehenPresented At:6th annual 24 Hours of Stem Cells™ virtual eventOCT 17, 2017 08:00 AM PDTC.E. CREDITS
OCT 17, 2017 08:00 AM PDTDATE: October 17, 2017TIME: 08:00am PDT, 11:00am EDTResearching and understanding the mechanisms of drug resistance are essential to determine therapies that are more effective on an in...Speaker: Yesim Gökmen-Polar, PhDSponsored By: Thermo Fisher Scientific - Applied BiosystemsSEP 27, 2017 12:00 PM PDTC.E. CREDITS
SEP 27, 2017 12:00 PM PDTCheckpoint blockade therapy for cancer has had tremendous impact on clinical outcomes, yet only a subset of patients respond. Recent studies show that response to checkpoint blockade does not...Speaker: Joshua Brody, MDPresented At:Cell Biology 2017JUL 25, 2017 09:00 AM PDT
JUL 25, 2017 09:00 AM PDTEVENT DETAILS:DATE: July 25, 2017TIME: 9:00am PT, Noon ETThermo Fisher Scientific is proud to present the SyncD3 webinar series. As a thought-leader in science...Speaker: David Piper, PhDSponsored By: Thermo Fisher Scientific
APR 09, 2019
09:00 AM PDT
C.E. CREDITS
APR 09, 2019
09:00 AM PDT
DATE: April 9, 2019TIME: 9:00 AM PDTWe will provide a general introduction to the Single-Cell Western Technology (SCW) and then present data from 2 ongoing projects from the Col...
Speaker:
Noemi Kedei, MD
,
Kelly Gardner, Ph.D.
Sponsored By: ProteinSimple
DEC 06, 2018
03:00 PM CET
C.E. CREDITS
DEC 06, 2018
03:00 PM CET
DATE: December 6, 2018TIME:6:00am PST, 9:00am EST, 3:00pm CET Alterations in the bone and mineral...
Speaker:
Jean-Claude Souberbielle (JCS)
Sponsored By: DiaSorin
OCT 30, 2018
10:00 AM PDT
C.E. CREDITS
OCT 30, 2018
10:00 AM PDT
DATE: October 30, 2018TIME: 10:00am PT, 1:00pm ET Identification and quantification of post-translational modifications (PTM) presents a unique challenge to proteomic studies...
Speaker:
Birgit Schilling, PhD
,
Matthew Stokes, PhD
Sponsored By: Cell Signaling Technology
OCT 11, 2018
01:30 PM PDT
C.E. CREDITS
OCT 11, 2018
01:30 PM PDT
As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...
Speaker:
Benjamin Anderson, MD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
12:00 PM PDT
C.E. CREDITS
OCT 11, 2018
12:00 PM PDT
Lung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...
Speaker:
Nicholas McGranahan, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
10:30 AM PDT
C.E. CREDITS
OCT 11, 2018
10:30 AM PDT
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
Speaker:
Kevin Williams, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
09:00 AM PDT
C.E. CREDITS
OCT 11, 2018
09:00 AM PDT
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
Speaker:
Jason De Melo, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
07:30 AM PDT
C.E. CREDITS
OCT 11, 2018
07:30 AM PDT
In the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...
Speaker:
Krastan Blagoev, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
06:00 AM PDT
C.E. CREDITS
OCT 11, 2018
06:00 AM PDT
PacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...
Speaker:
Jonas Korlach, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
12:00 PM PDT
C.E. CREDITS
OCT 10, 2018
12:00 PM PDT
RNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...
Speaker:
Jonathan Shaffer, MBA, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: QIAGEN
OCT 10, 2018
12:00 PM PDT
C.E. CREDITS
OCT 10, 2018
12:00 PM PDT
To date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...
Speaker:
Jerome Galon, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
09:00 AM PDT
C.E. CREDITS
OCT 10, 2018
09:00 AM PDT
In prior work, we have pursued how tumor reactive monoclonal antibody (mAb), together with activators of innate immune cells, like NK cells, can augment antibody dependent cell-mediated cytot...
Speaker:
Paul Sondel, MD, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
09:00 AM PDT
C.E. CREDITS
OCT 10, 2018
09:00 AM PDT
High-throughput screening is widely useful in identifying genes and pathways that drive changes in cell behavior such as cell cycle regulation, metastasis, and drug resistance. Millipor...
Speaker:
Andrew Ravanelli, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: MilliporeSigma
OCT 10, 2018
07:30 AM PDT
C.E. CREDITS
OCT 10, 2018
07:30 AM PDT
Molecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...
Speaker:
Karin Rodland, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
06:00 AM PDT
C.E. CREDITS
OCT 10, 2018
06:00 AM PDT
Understanding the immune repertoire is an important aspect of immuno-oncology research, which can be used to gather insights into the function and overall status of the immune system. We have...
Speaker:
Samuel Rulli, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: QIAGEN
MAR 15, 2018
09:00 AM PDT
C.E. CREDITS
MAR 15, 2018
09:00 AM PDT
The inability of neurons to regenerate damaged axons within the CNS has dire consequences for victims of traumatic or ischemic brain injury and multiple neurodegenerative diseases. Like other...
Speaker:
Larry Benowitz, PhD
Presented At:Neuroscience 2018
FEB 21, 2018
12:00 PM PST
C.E. CREDITS
FEB 21, 2018
12:00 PM PST
Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the Methyl CpG Binding Protein 2 (MECP2) gene. In mouse models of RTT, deficits in long-term potentiation (LTP) at...
Speaker:
Colleen Niswender, PhD
Presented At:Drug Discovery 2018
FEB 21, 2018
09:00 AM PST
C.E. CREDITS
FEB 21, 2018
09:00 AM PST
There are many tumor biomarkers but, they mostly reflect tumor mass or past growth, when what is more important is to obtain an indication of future growth and therapy response.Proliferat...
Speaker:
Martin Shaw
Presented At:Drug Discovery 2018
JAN 25, 2018
08:00 AM PST
C.E. CREDITS
JAN 25, 2018
08:00 AM PST
DATE: January 25, 2018TIME: 8:00AM PST, 10:00AM CSTProstate cancer (PCa) is the most common noncutaneous malignancy in men in the US. A significant fraction of advanced PCa treate...
Speaker:
Xin Lu, PhD
Sponsored By: Bio-Techne
NOV 14, 2017
09:00 AM PST
C.E. CREDITS
NOV 14, 2017
09:00 AM PST
DATE: November 14, 2017TIME: 09:00am PST, 12:00pm ESTThe CRISPR-Cas9 system has been adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and av...
Speaker:
Žaklina Strezoska
,
Benedict Cross
Sponsored By: Dharmacon, a Horizon Discovery Group Company
For more than four decades, restrictions on research with psychoactive drugs have slowed progress in understanding how such substances impact brain metabolism. Besides the historical restrict...
Speaker:
Stevens Rehen
Presented At:6th annual 24 Hours of Stem Cells™ virtual event
OCT 17, 2017
08:00 AM PDT
C.E. CREDITS
OCT 17, 2017
08:00 AM PDT
DATE: October 17, 2017TIME: 08:00am PDT, 11:00am EDTResearching and understanding the mechanisms of drug resistance are essential to determine therapies that are more effective on an in...
Speaker:
Yesim Gökmen-Polar, PhD
Sponsored By: Thermo Fisher Scientific - Applied Biosystems
SEP 27, 2017
12:00 PM PDT
C.E. CREDITS
SEP 27, 2017
12:00 PM PDT
Checkpoint blockade therapy for cancer has had tremendous impact on clinical outcomes, yet only a subset of patients respond. Recent studies show that response to checkpoint blockade does not...
Speaker:
Joshua Brody, MD
Presented At:Cell Biology 2017
JUL 25, 2017
09:00 AM PDT
JUL 25, 2017
09:00 AM PDT
EVENT DETAILS:DATE: July 25, 2017TIME: 9:00am PT, Noon ETThermo Fisher Scientific is proud to present the SyncD3 webinar series. As a thought-leader in science...
Speaker:
David Piper, PhD
Sponsored By: Thermo Fisher Scientific
- Fat
- Neurons
- Rare Disease
- Clinical Trials
- Chemotherapy
- Animal Models
- Cancer Therapeutics
- Therapeutics
- Drug Discovery
- Cell Therapy
- Cell Death
- Gene Expression
- Pediatrics
- Gene Therapy
- Blood
- Immunology
- ALS
- Cell Line Development
- Cancer Research
- Oncology
- Genetics
- Pre-Clinical
- Small Molecule
- Protein Expression
- Rare Diseases
- Human Biology
- Clinical Oncology
- Clinical Research
- Genomics
- Biomedical Research
- DNA
- Clinical Genetics
- Cancer
- Biopharmaceutical
- Apoptosis
- Stress
- Cell Biology
- Pharmaceuticals
